Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-x(L) and bak expression

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 2039-2046

  Liu, Qiang Yuan ^a   Stein, C A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRAMUSTINE; PACLITAXEL; PROTEIN BCL 2;

ARTICLE; CHROMATIN CONDENSATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; ESTRAMUSTINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; KINETICS; MALE; MEMBRANE PROTEINS; PACLITAXEL; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030717131     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hoffman, B., and Liebermann, D. A. Molecular controls of apoptosis: differentiation/growth arrest, primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene, 9: 1807-1812, 1994.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
3. Bakhshi, A., Jensen, J. P., Goldman, P., Weight, J. J., McBride, O. W., Epstein, A. L., and Korsmeyer, S. J. Cloning the chromosomal break point of the t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41: 889-906, 1985.
4. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., and Croce, C. M. The t(14:18) chromosome translocations involved in B cell neoplasms result from mistakes in VDJ joining. Science (Washington DC), 229: 1390-1393, 1985.
5. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson C. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell, 74: 597-608, 1993.
6. Oltvai, Z. N., Millman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
7. Nunez, G., and Clarke, M. F. The bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol., 4: 399-403, 1994.
8. Fisler, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
9. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
10. Fuchs, D. A., and Johnson, R. K. Cytologic evidence that Taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat. Rep., 62: 479-487, 1978.
11. Manfredi, J. J., Fant, J., and Horwitz, S. B. Taxol induces the formation of unusual arrays of cellular microtubules in colchicine-pretreated J774.2 cells. Eur. J. Cell Biol., 42: 126-134, 1986.
12. Manfredi, J. J., and Horwitz, S. B. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol. Ther., 25: 83-125; 1984.
13. DeBrabander, M., Geuens, G., Nuydens, R., Willebrords, R., and DeMey, J. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc. Natl. Acad. Sci. USA, 78: 5608-5612, 1981.
14. Speicher, L., Barone, L., and Tew, K. Combined antimicrotubule activity of estramustine and Taxol in human prostatic carcinoma cell lines. Cancer Res., 52: 4433-4440, 1992.
15. Crossin, K. L., and Carney, D. H. Microtubule stabilization by Taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell, 27: 341-350, 1981.
16. Rowinsky, E. K., Cazanave, L. A., and Donehower, R. C. Taxol: a novel investigational antimicrotubule agent. J. Natl. Cancer Inst., 82: 1247-1259, 1990.
17. Stearns, M. E., and Tew, K. D. Antimicrotubule effects of estramustine, an antiprostatic tumor drug. Cancer Res., 45: 3891-3897, 1985.
18. Hudes, G. R., Nathan, F. E., Khater, C., Greenberg, R., Gomella, L., Stern, C., and McAleer, C. Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin. Oncol., 22 (Suppl. 12): 41-45, 1995.
19. Danesi, R., Figg, W. D., Reed, E., and Myers, C. E. Paclitaxel (Taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol. Pharmacol., 47: 1106-1111, 1995.
20. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
21. Haldar, S., Jena, N., and Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
22. Farrow, S., White, J., Martinou, I., Raven, K., Grinham, C., Martnou, J., and Brown, R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (Lond.), 374: 731-733, 1995.
23. Chittenden, T., Harrington, E., O'Connor, R., Flemington, C., Lutz, R., Evan, G., and Guild, B. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.), 374: 733-736, 1995.
24. Kiefer, M., Brauer, M., Powers, V., Wu, J., Umamsky, S., Tomei, D., and Barr, P. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.), 374: 736-739, 1995.
25. Raffo, A., Perlman, H., Chen, M-W., Day, M., Streitman, J., and Buttyan, R. Overexpression of Bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res., 55: 4438-4445, 1995.
26. Hermann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W., and Kalden, J. R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res., 22: 5506-5507, 1994.
27. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed., pp. 7.19-9.25. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
28. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
29. Krajewski, S., Krajewski, M., Shabaik, A., Wang, H-G., Shinji, I., Fong, L., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res., 54: 5501-5507, 1994.
30. L. Blood, 87: 8337-8343, 1996.
31. L in the control of apoptosis in murine myeloma cells. Cancer Res., 56: 1451-1456, 1996.
32. L. Cancer Res., 56: 1621-1628, 1996.
33. Krajewski, M., Krajewski, S., Epstein, J., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., and Reed, J. Immunohistochemical analysis of Bcl-2, Bax, Bcl-x, and mcl-1 expression in prostate cancers. Am. J. Pathol., 148: 1567-1576, 1996.
34. L can confer a multidrug resistance phenotype. Blood, 86: 1903-1910, 1995.
35. Yagoda, A., and Petrylak, P. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer (Phila.), 71 (Suppl. 3): 1098-1109, 1993.